Several health organizations, including the U.S. Centers for Disease Control, have recommended dose reduction and risk mitigation strategies to reduce adverse events for patients on chronic opioid therapy. A new study published in The Journal of Pain reports that patients with chronic pain treated in centers with opioid-dose reduction policies show no clinically meaningful differences in pain intensity, interference with daily activities, enjoyment of life, or depressive symptoms.